To another query on US President Trump's policy impact on India, pharma, Kumar said that there ... I also don't think, there will not be any problem for the Indian pharmaceutical, biotech and information technology sector,” he said.
Read more: Cardiac stent notification by mid-Feb, mandatory UCPMP on the cards, US President Trump's ...